CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

NCT01540604 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy
Becker Muscular Dystrophy

Interventions

DRUG: CRD007

Sponsor

RSPR Pharma AB